Database » Life Sciences Companies » Therapeutics
Show companies:

Therapeutics

Results: 1-10 out of 22  |   Next 10 »

  • ABIC Biological Laboratories Ltd.
    ABIC Biological Laboratories Ltd. has been producing high quality veterinary products since 1939. Our company is focused on developing,...
  • Athena Cardionet Ltd.
    Athena Cardionet Ltd. is an emerging pharmaceutical company focusing on inhibition of metal ion dependent pathological processes; prevention...
  • AVA
    AVA is developing special molecules that will be planted into cells. The company's technology will cause a borne animal to be resistant...
  • BioCancell Therapeutics Ltd.
    BioCancell is specializing in the development of patient-oriented, targeted therapy for the treatment of a wide range of cancers based...
  • CellCure Neurosciences Ltd.
    Cell Cure Neurosciences was established towards the end of 2005 as an Israeli subsidiary of ES Cell International Pte Ltd with a well...
  • Enlivex Therapeutics Ltd. (Formerly Tolarex)
    Enlivex is a biotechnology company focused on the development of cell therapies for the induction of immune tolerance in autoimmune...
  • Gamida Cell Ltd.
    Gamida-Cell is a leader in the expansion of stem cell therapeutics utilizing small molecules to stimulate stem cell self-renewal,...
  • Immune System Key (ISK) Ltd.
    ISK was founded in 2005 by by Dr. Yoram Devary, Chairman of the Biochemistry Department and Prof. Uziel Sandler of the Department of...
  • Immunity Pharma Ltd. (IPL)
      Immunity Pharma Ltd. (IPL) is a drug development company that uses...
  • Innovo Mimetics Ltd (IML)
    Innovo Mimetics Ltd (IML) offers an alternative to cancer research in sentient animals (mice) – growing cancer in chicken...
Results: 1-10 out of 22  |   Next 10 »

Did You Know?

  • The Hebrew University ranks 12th worldwide in biotechnology patents.
     
  • $2 billion in annual sales are generated from two life science products originating from scientific innovation at the Hebrew University of Jerusalem. These include Exelon (marketed by Novartis) for the treatment of Alzheimer’s disease and Doxil (marketed by J&J) for the treatment of cancer..